BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 19, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Adderall and Adderall XR amphetamine neurology data

Researchers at Kaiser Permanente and colleagues reported data from a pair of retrospective cohort studies in a total of 443,198 adults aged 25-64 years from 4 healthcare claims databases showing that there was no evidence of an increased risk of serious cardiovascular events, including myocardial infarction (MI), sudden cardiovascular death or stroke, for current users of ADHD medications compared to non-users. Specifically, the adjusted rate ratio of serious cardiovascular events for current users vs. non-users of ADHD medications was 0.83. FDA said that although the rate was lower with ADHD drug use vs. non-use, the agency is not concluding that...

Read the full 478 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >